Advertisement

Index by author

October 01, 1993; Volume 267,Issue 1

A

  1. Abbott, F S

    1. Transplacental and nonplacental clearances, metabolism and pharmacodynamics of labetalol in the fetal lamb after direct intravenous administration.
      K Yeleswaram, D W Rurak, E Kwan, C Hall, A Doroudian, M R Wright, F S Abbott and J E Axelson
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 425-431;

  2. Aguila-Mansilla, N

    1. Localization of a defect in hypothalamic dopaminergic neurons of the aged brain that results in impaired PKA-dependent activation of tyrosine hydroxylase.
      N Aguila-Mansilla, W Kedzierski and J C Porter
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 171-175;

  3. Ahr, H J

    1. BAY X1005, a new inhibitor of leukotriene synthesis: in vivo inflammation pharmacology and pharmacokinetics.
      R Müller-Peddinghaus, C Kohlsdorfer, P Theisen-Popp, R Fruchtmann, E Perzborn, B Beckermann, K Bühner, H J Ahr and K H Mohrs
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 51-57;

  4. Akar, C A

    1. Neuropeptide FF receptors: structure-activity relationship and effect of morphine.
      K Payza, C A Akar and H Y Yang
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 88-94;

  5. Alesdatter, J E

    1. Involvement of N-methyl-D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine.
      P W Kalivas and J E Alesdatter
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 486-495;

  6. Apseloff, G

    1. Effects of aminohydroxybutane bisphosphonate on bone growth when administered after hind-limb bone loss in tail-suspended rats.
      G Apseloff, B Girten, S E Weisbrode, M Walker, L S Stern, M E Krecic and N Gerber
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 515-521;

  7. Arneric, S P

    1. Nicotinic agonists modulate basal forebrain control of cortical cerebral blood flow in anesthetized rats.
      D G Linville, S Williams, J L Raszkiewicz and S P Arneric
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 440-448;

  8. Asaad, M M

    1. Combined inhibition of neutral endopeptidase and angiotensin converting enzyme in cardiomyopathic hamsters with compensated heart failure.
      N C Trippodo, M Fox, V Natarajan, B C Panchal, C R Dorso and M M Asaad
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 108-116;

  9. Axelson, J E

    1. Transplacental and nonplacental clearances, metabolism and pharmacodynamics of labetalol in the fetal lamb after direct intravenous administration.
      K Yeleswaram, D W Rurak, E Kwan, C Hall, A Doroudian, M R Wright, F S Abbott and J E Axelson
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 425-431;

B

  1. Baecher-Steppan, L

    1. Polychlorinated biphenyl-induced immune suppression: castration, but not adrenalectomy or RU 38486 treatment, partially restores the suppressed cytotoxic T lymphocyte response to alloantigen.
      G K De Krey, L Baecher-Steppan, J A Deyo, B Smith and N I Kerkvliet
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 308-315;

  2. Bakhtiarian, A

    1. Possible novel action of ouabain: allosteric modulation of vascular serotonergic (5-HT2) and angiotensinergic (AT1) receptors.
      R E Purdy, B A Prins, M A Weber, A Bakhtiarian, J R Smith, M K Kim, T H Nguyen and E W Weiler
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 228-237;

  3. Baraban, J M

    1. Activation of transcription factor genes in striatum by cocaine: role of both serotonin and dopamine systems.
      R V Bhat and J M Baraban
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 496-505;

  4. Barrett, J E

    1. The discriminative stimulus effects of cocaine in pigeons.
      C E Johanson and J E Barrett
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 1-8;

  5. Barthlow, H G

    1. Pharmacological examination of receptors mediating contractile responses to tachykinins in airways isolated from human, guinea pig and hamster.
      J L Ellis, B J Undem, J S Kays, S V Ghanekar, H G Barthlow and C K Buckner
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 95-101;

  6. Beckermann, B

    1. BAY X1005, a new inhibitor of leukotriene synthesis: in vivo inflammation pharmacology and pharmacokinetics.
      R Müller-Peddinghaus, C Kohlsdorfer, P Theisen-Popp, R Fruchtmann, E Perzborn, B Beckermann, K Bühner, H J Ahr and K H Mohrs
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 51-57;

  7. Bédard, P J

    1. Differential effect of selective D-1 and D-2 dopamine receptor agonists on levodopa-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- exposed monkeys.
      P Blanchet, P J Bédard, D R Britton and J W Kebabian
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 275-279;

  8. Benvenga, M J

    1. Preclinical studies on LY228729: a potent and selective serotonin1A agonist.
      M M Foreman, R W Fuller, J D Leander, M J Benvenga, D T Wong, D L Nelson, D O Calligaro, S P Swanson, J B Lucot and M E Flaugh
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 58-71;

  9. Berger, P

    1. Effects of cocaine alone and in combination with mazindol in human cocaine abusers.
      K L Preston, J T Sullivan, P Berger and G E Bigelow
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 296-307;

  10. Bhagwat, S V

    1. Cerebral flavin-containing monooxygenase-mediated metabolism of antidepressants in brain: immunochemical properties and immunocytochemical localization.
      S Bhamre, S V Bhagwat, S K Shankar, D E Williams and V Ravindranath
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 555-559;

  11. Bhamre, S

    1. Cerebral flavin-containing monooxygenase-mediated metabolism of antidepressants in brain: immunochemical properties and immunocytochemical localization.
      S Bhamre, S V Bhagwat, S K Shankar, D E Williams and V Ravindranath
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 555-559;

  12. Bhat, R V

    1. Activation of transcription factor genes in striatum by cocaine: role of both serotonin and dopamine systems.
      R V Bhat and J M Baraban
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 496-505;

  13. Bickel, C A

    1. The effects of the potent glucocorticoid budesonide on adhesion of eosinophils to human vascular endothelial cells and on endothelial expression of adhesion molecules.
      J Kaiser, C A Bickel, B S Bochner and R P Schleimer
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 245-249;

  14. Bigelow, G E

    1. Effects of cocaine alone and in combination with mazindol in human cocaine abusers.
      K L Preston, J T Sullivan, P Berger and G E Bigelow
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 296-307;

  15. Blanchet, P

    1. Differential effect of selective D-1 and D-2 dopamine receptor agonists on levodopa-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- exposed monkeys.
      P Blanchet, P J Bédard, D R Britton and J W Kebabian
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 275-279;

  16. Blandina, P

    1. Serotonergic modulation of L-glutamic acid-evoked release of endogenous norepinephrine from rat hypothalamus.
      J Goldfarb, J Walcott and P Blandina
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 45-50;

  17. Bloom, F E

    1. Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: genetic and motivational determinants.
      F Weiss, M T Lorang, F E Bloom and G F Koob
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 250-258;

  18. Bochner, B S

    1. The effects of the potent glucocorticoid budesonide on adhesion of eosinophils to human vascular endothelial cells and on endothelial expression of adhesion molecules.
      J Kaiser, C A Bickel, B S Bochner and R P Schleimer
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 245-249;

  19. Bodewei, R

    1. Anticonvulsant and related effects of U-54494A in various seizure tests.
      W Fischer, R Bodewei, P F VonVoigtlander and M Müller
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 163-170;

  20. Botella, A

    1. Platelet-activating factor (PAF) induces a contraction of isolated smooth muscle cells from guinea pig ileum: intracellular pathway involved.
      O Jeanneton, M Delvaux, A Botella, J Frexinos and L Bueno
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 31-37;

  21. Bowen, W D

    1. Modulation of morphine antinociception by swim-stress in the mouse: involvement of supraspinal opioid delta-2 receptors.
      T W Vanderah, K D Wild, A E Takemori, M Sultana, P S Portoghese, W D Bowen, V J Hruby, H I Mosberg and F Porreca
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 449-455;

  22. Breese, G R

    1. Molecular basis for regionally specific action of ethanol on gamma-aminobutyric acidA receptors: generalization to other ligand-gated ion channels.
      H E Criswell, P E Simson, G E Duncan, T J McCown, J S Herbert, A L Morrow and G R Breese
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 522-537;

  23. Britton, D R

    1. Differential effect of selective D-1 and D-2 dopamine receptor agonists on levodopa-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- exposed monkeys.
      P Blanchet, P J Bédard, D R Britton and J W Kebabian
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 275-279;

  24. Brown, R D

    1. Hepatic and splenic phagocytosis in female B6C3F1 mice implanted with morphine sulfate pellets.
      D G Levier, R D Brown, J A McCay, B A Fuchs, L S Harris and A E Munson
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 357-363;

  25. Bruenger, F W

    1. Duration and dose-related effects of an orally administered, partially lipophilic polyaminocarboxylic acid on the decorporation of plutonium and americium.
      S C Miller, F W Bruenger, G Kuswik-Rabiega, G Liu and R D Lloyd
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 548-554;

  26. Bryce, D K

    1. Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor.
      S McLean, A Ganong, P A Seymour, R M Snider, M C Desai, T Rosen, D K Bryce, K P Longo, L S Reynolds and G Robinson
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 472-479;

  27. Buckner, C K

    1. Pharmacological examination of receptors mediating contractile responses to tachykinins in airways isolated from human, guinea pig and hamster.
      J L Ellis, B J Undem, J S Kays, S V Ghanekar, H G Barthlow and C K Buckner
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 95-101;

  28. Bueno, L

    1. Platelet-activating factor (PAF) induces a contraction of isolated smooth muscle cells from guinea pig ileum: intracellular pathway involved.
      O Jeanneton, M Delvaux, A Botella, J Frexinos and L Bueno
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 31-37;

  29. Bühner, K

    1. BAY X1005, a new inhibitor of leukotriene synthesis: in vivo inflammation pharmacology and pharmacokinetics.
      R Müller-Peddinghaus, C Kohlsdorfer, P Theisen-Popp, R Fruchtmann, E Perzborn, B Beckermann, K Bühner, H J Ahr and K H Mohrs
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 51-57;

  30. Burke, T J

    1. Calcium modulation and cell injury in isolated rat proximal tubules.
      J F Wetzels, L Yu, X Wang, A Kribben, T J Burke and R W Schrier
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 176-180;

  31. Butelman, E R

    1. Opioid thermal antinociception in rhesus monkeys: receptor mechanisms and temperature dependency.
      E A Walker, E R Butelman, B R DeCosta and J H Woods
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 280-286;

  32. Búzás, B

    1. Differential regulation of adenylyl cyclase activity by mu and delta opioids in rat caudate putamen and nucleus accumbens.
      S Izenwasser, B Búzás and B M Cox
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 145-152;

  33. Bymaster, F P

    1. Comparative behavioral and neurochemical activities of cholinergic antagonists in rats.
      F P Bymaster, I Heath, J C Hendrix and H E Shannon
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 16-24;

  34. Byrd, L D

    1. Effects of CGS 15943, a nonxanthine adenosine antagonist, on behavior in the squirrel monkey.
      L L Howell and L D Byrd
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 432-439;

C

  1. Calligaro, D O

    1. Preclinical studies on LY228729: a potent and selective serotonin1A agonist.
      M M Foreman, R W Fuller, J D Leander, M J Benvenga, D T Wong, D L Nelson, D O Calligaro, S P Swanson, J B Lucot and M E Flaugh
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 58-71;

  2. Carr, D J

    1. Immune alterations in morphine-treated rhesus monkeys.
      D J Carr and C P France
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 9-15;

  3. Cavallaro, S

    1. Stimulation of brain steroidogenesis by 2-aryl-indole-3-acetamide derivatives acting at the mitochondrial diazepam-binding inhibitor receptor complex.
      E Romeo, S Cavallaro, A Korneyev, A P Kozikowski, D Ma, A Polo, E Costa and A Guidotti
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 462-471;

  4. Cawley, T A

    1. Effect of chronic neuroleptic treatment on central and peripheral muscarinic receptors.
      T A Cawley, T J Shickley, M R Ruggieri and G R Luthin
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 134-139;

  5. Cederbaum, A I

    1. Ethanol consumption by the nursing mother induces cytochrome P-4502E1 in neonatal rat liver.
      D Wu and A I Cederbaum
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 560-566;

  6. Chen, N H

    1. [3H]dopamine and [3H]serotonin release in vitro induced by electrical stimulation in A9 and A10 dopamine regions of rat brain: characterization and responsiveness to cocaine.
      N H Chen and M E Reith
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 379-389;

  7. Chovan, J P

    1. Development of tolerance to the antihypertensive effects of highly selective adenosine A2a agonists upon chronic administration.
      R L Webb, M A Sills, J P Chovan, J V Peppard and J E Francis
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 287-295;

  8. Codd, E E

    1. Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol.
      R B Raffa, E Friderichs, W Reimann, R P Shank, E E Codd, J L Vaught, H I Jacoby and N Selve
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 331-340;

  9. Colpaert, F C

    1. Inhibition of methylphenidate-induced behaviors in rats: differences among neuroleptics.
      W Koek and F C Colpaert
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 181-191;

  10. Costa, E

    1. Stimulation of brain steroidogenesis by 2-aryl-indole-3-acetamide derivatives acting at the mitochondrial diazepam-binding inhibitor receptor complex.
      E Romeo, S Cavallaro, A Korneyev, A P Kozikowski, D Ma, A Polo, E Costa and A Guidotti
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 462-471;

  11. Côté, T E

    1. Naltrexone-induced upregulation of mu opioid receptors on 7315c cell and brain membranes: enhancement of opioid efficacy in inhibiting adenylyl cyclase.
      T E Côté, S Izenwasser and H B Weems
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 238-244;

  12. Cox, B M

    1. Differential regulation of adenylyl cyclase activity by mu and delta opioids in rat caudate putamen and nucleus accumbens.
      S Izenwasser, B Búzás and B M Cox
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 145-152;

  13. Criswell, H E

    1. Molecular basis for regionally specific action of ethanol on gamma-aminobutyric acidA receptors: generalization to other ligand-gated ion channels.
      H E Criswell, P E Simson, G E Duncan, T J McCown, J S Herbert, A L Morrow and G R Breese
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 522-537;

  14. Curtis, B A

    1. Dose-dependent antagonism and potentiation of nitrous oxide antinociception by naloxone in mice.
      R M Quock, B A Curtis, B J Reynolds and J L Mueller
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 117-122;

D

  1. Davis, J N

    1. Extracellular catecholamine levels in rat hippocampus after a selective alpha-2 adrenoceptor antagonist or a selective dopamine uptake inhibitor: evidence for dopamine release from local dopaminergic nerve terminals.
      K Xu, L Näveri, K U Frerichs, J M Hallenbeck, G Feuerstein, J N Davis and A L Sirén
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 211-217;

  2. de Avellar, M C

    1. Age-related changes in norepinephrine release and its modulation by presynaptic alpha-2 adrenoceptors in the rat vas deferens.
      M C de Avellar and R P Markus
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 38-44;

  3. DeCosta, B R

    1. Opioid thermal antinociception in rhesus monkeys: receptor mechanisms and temperature dependency.
      E A Walker, E R Butelman, B R DeCosta and J H Woods
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 280-286;

  4. De Krey, G K

    1. Polychlorinated biphenyl-induced immune suppression: castration, but not adrenalectomy or RU 38486 treatment, partially restores the suppressed cytotoxic T lymphocyte response to alloantigen.
      G K De Krey, L Baecher-Steppan, J A Deyo, B Smith and N I Kerkvliet
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 308-315;

  5. Delvaux, M

    1. Platelet-activating factor (PAF) induces a contraction of isolated smooth muscle cells from guinea pig ileum: intracellular pathway involved.
      O Jeanneton, M Delvaux, A Botella, J Frexinos and L Bueno
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 31-37;

  6. Desai, M C

    1. Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor.
      S McLean, A Ganong, P A Seymour, R M Snider, M C Desai, T Rosen, D K Bryce, K P Longo, L S Reynolds and G Robinson
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 472-479;

  7. De Vries, T J

    1. Mu- and delta-opioid receptors inhibitorily linked to dopamine-sensitive adenylate cyclase in rat striatum display a selectivity profile toward endogenous opioid peptides different from that of presynaptic mu, delta and kappa receptors.
      A N Schoffelmeer, T J De Vries, F Hogenboom and A H Mulder
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 205-210;

  8. Deyo, J A

    1. Polychlorinated biphenyl-induced immune suppression: castration, but not adrenalectomy or RU 38486 treatment, partially restores the suppressed cytotoxic T lymphocyte response to alloantigen.
      G K De Krey, L Baecher-Steppan, J A Deyo, B Smith and N I Kerkvliet
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 308-315;

  9. Doroudian, A

    1. Transplacental and nonplacental clearances, metabolism and pharmacodynamics of labetalol in the fetal lamb after direct intravenous administration.
      K Yeleswaram, D W Rurak, E Kwan, C Hall, A Doroudian, M R Wright, F S Abbott and J E Axelson
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 425-431;

  10. Dorso, C R

    1. Combined inhibition of neutral endopeptidase and angiotensin converting enzyme in cardiomyopathic hamsters with compensated heart failure.
      N C Trippodo, M Fox, V Natarajan, B C Panchal, C R Dorso and M M Asaad
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 108-116;

  11. Duncan, G E

    1. Molecular basis for regionally specific action of ethanol on gamma-aminobutyric acidA receptors: generalization to other ligand-gated ion channels.
      H E Criswell, P E Simson, G E Duncan, T J McCown, J S Herbert, A L Morrow and G R Breese
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 522-537;

  12. Dunlow, L D

    1. Antinociceptive activity of intrathecally administered potassium channel openers and opioid agonists: a common mechanism of action?
      S P Welch and L D Dunlow
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 390-399;

  13. Dworkin, S I

    1. Effects of intracerebroventricular administration of beta-funaltrexamine on [3H]DAMGO binding to rat brain sections.
      T J Martin, S I Dworkin and J E Smith
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 506-514;

  14. Dytko, G

    1. Urea transport in toad skin (Bufo marinus)
      G Dytko, P L Smith and L B Kinter
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 364-370;

  15. Dzwonczyk, S

    1. Cardioprotective effects of a novel calcium antagonist related to the structure of cromakalim.
      G J Grover, P G Sleph, S Dzwonczyk and J R McCullough
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 102-107;

E

  1. Ellis, J L

    1. Pharmacological examination of receptors mediating contractile responses to tachykinins in airways isolated from human, guinea pig and hamster.
      J L Ellis, B J Undem, J S Kays, S V Ghanekar, H G Barthlow and C K Buckner
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 95-101;

F

  1. Feuerstein, G

    1. Extracellular catecholamine levels in rat hippocampus after a selective alpha-2 adrenoceptor antagonist or a selective dopamine uptake inhibitor: evidence for dopamine release from local dopaminergic nerve terminals.
      K Xu, L Näveri, K U Frerichs, J M Hallenbeck, G Feuerstein, J N Davis and A L Sirén
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 211-217;

  2. Fischer, W

    1. Anticonvulsant and related effects of U-54494A in various seizure tests.
      W Fischer, R Bodewei, P F VonVoigtlander and M Müller
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 163-170;

  3. Flaugh, M E

    1. Preclinical studies on LY228729: a potent and selective serotonin1A agonist.
      M M Foreman, R W Fuller, J D Leander, M J Benvenga, D T Wong, D L Nelson, D O Calligaro, S P Swanson, J B Lucot and M E Flaugh
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 58-71;

  4. Foreman, M M

    1. Preclinical studies on LY228729: a potent and selective serotonin1A agonist.
      M M Foreman, R W Fuller, J D Leander, M J Benvenga, D T Wong, D L Nelson, D O Calligaro, S P Swanson, J B Lucot and M E Flaugh
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 58-71;

  5. Fox, M

    1. Combined inhibition of neutral endopeptidase and angiotensin converting enzyme in cardiomyopathic hamsters with compensated heart failure.
      N C Trippodo, M Fox, V Natarajan, B C Panchal, C R Dorso and M M Asaad
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 108-116;

  6. France, C P

    1. Immune alterations in morphine-treated rhesus monkeys.
      D J Carr and C P France
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 9-15;

  7. Francis, J E

    1. Development of tolerance to the antihypertensive effects of highly selective adenosine A2a agonists upon chronic administration.
      R L Webb, M A Sills, J P Chovan, J V Peppard and J E Francis
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 287-295;

  8. Frerichs, K U

    1. Extracellular catecholamine levels in rat hippocampus after a selective alpha-2 adrenoceptor antagonist or a selective dopamine uptake inhibitor: evidence for dopamine release from local dopaminergic nerve terminals.
      K Xu, L Näveri, K U Frerichs, J M Hallenbeck, G Feuerstein, J N Davis and A L Sirén
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 211-217;

  9. Frexinos, J

    1. Platelet-activating factor (PAF) induces a contraction of isolated smooth muscle cells from guinea pig ileum: intracellular pathway involved.
      O Jeanneton, M Delvaux, A Botella, J Frexinos and L Bueno
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 31-37;

  10. Friderichs, E

    1. Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol.
      R B Raffa, E Friderichs, W Reimann, R P Shank, E E Codd, J L Vaught, H I Jacoby and N Selve
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 331-340;

  11. Fruchtmann, R

    1. BAY X1005, a new inhibitor of leukotriene synthesis: in vivo inflammation pharmacology and pharmacokinetics.
      R Müller-Peddinghaus, C Kohlsdorfer, P Theisen-Popp, R Fruchtmann, E Perzborn, B Beckermann, K Bühner, H J Ahr and K H Mohrs
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 51-57;

  12. Fuchs, B A

    1. Hepatic and splenic phagocytosis in female B6C3F1 mice implanted with morphine sulfate pellets.
      D G Levier, R D Brown, J A McCay, B A Fuchs, L S Harris and A E Munson
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 357-363;

  13. Fuller, R W

    1. Possible involvement of dopamine in the long-term serotonin depletion by p-chloroamphetamine and beta,beta-difluoro-p-chloroamphetamine in rats.
      M G Henderson, K W Perry and R W Fuller
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 417-424;
    2. Preclinical studies on LY228729: a potent and selective serotonin1A agonist.
      M M Foreman, R W Fuller, J D Leander, M J Benvenga, D T Wong, D L Nelson, D O Calligaro, S P Swanson, J B Lucot and M E Flaugh
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 58-71;

  14. Furchgott, R F

    1. Inhibition by sulfhydryl compounds of vascular relaxation induced by nitric oxide and endothelium-derived relaxing factor.
      L Jia and R F Furchgott
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 371-378;

G

  1. Ganguly, T

    1. Prolactin increases Na+/taurocholate cotransport in isolated hepatocytes from postpartum rats and ovariectomized rats.
      T Ganguly, J F Hyde and M Vore
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 82-87;

  2. Ganong, A

    1. Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor.
      S McLean, A Ganong, P A Seymour, R M Snider, M C Desai, T Rosen, D K Bryce, K P Longo, L S Reynolds and G Robinson
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 472-479;

  3. Gekle, M

    1. Mechanism of ochratoxin A-induced reduction of glomerular filtration rate in rats.
      M Gekle and S Silbernagl
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 316-321;

  4. Gerber, N

    1. Effects of aminohydroxybutane bisphosphonate on bone growth when administered after hind-limb bone loss in tail-suspended rats.
      G Apseloff, B Girten, S E Weisbrode, M Walker, L S Stern, M E Krecic and N Gerber
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 515-521;

  5. Ghanekar, S V

    1. Pharmacological examination of receptors mediating contractile responses to tachykinins in airways isolated from human, guinea pig and hamster.
      J L Ellis, B J Undem, J S Kays, S V Ghanekar, H G Barthlow and C K Buckner
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 95-101;

  6. Girten, B

    1. Effects of aminohydroxybutane bisphosphonate on bone growth when administered after hind-limb bone loss in tail-suspended rats.
      G Apseloff, B Girten, S E Weisbrode, M Walker, L S Stern, M E Krecic and N Gerber
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 515-521;

  7. Goldberg, S R

    1. Cocaine: cardiovascular effects in relation to inhibition of peripheral neuronal monoamine uptake and central stimulation of the sympathoadrenal system.
      S R Tella, C W Schindler and S R Goldberg
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 153-162;

  8. Goldfarb, J

    1. Serotonergic modulation of L-glutamic acid-evoked release of endogenous norepinephrine from rat hypothalamus.
      J Goldfarb, J Walcott and P Blandina
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 45-50;

  9. Grimminger, F

    1. Differential vasoconstrictor potencies of free fatty acids in the lung vasculature: 2-versus 3-series prostanoid generation.
      F Grimminger, K Mayer, H J Krämer, J Stevens, D Walmrath and W Seeger
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 259-265;

  10. Grover, G J

    1. Cardioprotective effects of a novel calcium antagonist related to the structure of cromakalim.
      G J Grover, P G Sleph, S Dzwonczyk and J R McCullough
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 102-107;

  11. Guidotti, A

    1. Stimulation of brain steroidogenesis by 2-aryl-indole-3-acetamide derivatives acting at the mitochondrial diazepam-binding inhibitor receptor complex.
      E Romeo, S Cavallaro, A Korneyev, A P Kozikowski, D Ma, A Polo, E Costa and A Guidotti
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 462-471;

H

  1. Hall, C

    1. Transplacental and nonplacental clearances, metabolism and pharmacodynamics of labetalol in the fetal lamb after direct intravenous administration.
      K Yeleswaram, D W Rurak, E Kwan, C Hall, A Doroudian, M R Wright, F S Abbott and J E Axelson
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 425-431;

  2. Hallenbeck, J M

    1. Extracellular catecholamine levels in rat hippocampus after a selective alpha-2 adrenoceptor antagonist or a selective dopamine uptake inhibitor: evidence for dopamine release from local dopaminergic nerve terminals.
      K Xu, L Näveri, K U Frerichs, J M Hallenbeck, G Feuerstein, J N Davis and A L Sirén
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 211-217;

  3. Hao, J X

    1. Systemic excitatory amino acid receptor antagonists of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor and of the N-methyl-D-aspartate (NMDA) receptor relieve mechanical hypersensitivity after transient spinal cord ischemia in rats.
      X J Xu, J X Hao, A Seiger and Z Wiesenfeld-Hallin
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 140-144;

  4. Harris, L S

    1. Hepatic and splenic phagocytosis in female B6C3F1 mice implanted with morphine sulfate pellets.
      D G Levier, R D Brown, J A McCay, B A Fuchs, L S Harris and A E Munson
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 357-363;

  5. Heath, I

    1. Comparative behavioral and neurochemical activities of cholinergic antagonists in rats.
      F P Bymaster, I Heath, J C Hendrix and H E Shannon
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 16-24;

  6. Henderson, M G

    1. Possible involvement of dopamine in the long-term serotonin depletion by p-chloroamphetamine and beta,beta-difluoro-p-chloroamphetamine in rats.
      M G Henderson, K W Perry and R W Fuller
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 417-424;

  7. Hendrix, J C

    1. Comparative behavioral and neurochemical activities of cholinergic antagonists in rats.
      F P Bymaster, I Heath, J C Hendrix and H E Shannon
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 16-24;

  8. Herbert, J S

    1. Molecular basis for regionally specific action of ethanol on gamma-aminobutyric acidA receptors: generalization to other ligand-gated ion channels.
      H E Criswell, P E Simson, G E Duncan, T J McCown, J S Herbert, A L Morrow and G R Breese
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 522-537;

  9. Hisa, H

    1. Effects of nifedipine, 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate hydrochloride and atrial natriuretic peptide on endothelin-induced antinatriuresis in dogs.
      H Takagi, A Takahara, Y Tomura, T Yamagata, H Hisa and S Satoh
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 456-461;

  10. Hitzemann, B A

    1. On the relationship between D2 receptor density and neuroleptic-induced catalepsy among eight inbred strains of mice.
      S J Kanes, B A Hitzemann and R J Hitzemann
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 538-547;

  11. Hitzemann, R J

    1. On the relationship between D2 receptor density and neuroleptic-induced catalepsy among eight inbred strains of mice.
      S J Kanes, B A Hitzemann and R J Hitzemann
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 538-547;

  12. Hogenboom, F

    1. Mu- and delta-opioid receptors inhibitorily linked to dopamine-sensitive adenylate cyclase in rat striatum display a selectivity profile toward endogenous opioid peptides different from that of presynaptic mu, delta and kappa receptors.
      A N Schoffelmeer, T J De Vries, F Hogenboom and A H Mulder
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 205-210;

  13. Howell, L L

    1. Effects of CGS 15943, a nonxanthine adenosine antagonist, on behavior in the squirrel monkey.
      L L Howell and L D Byrd
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 432-439;

  14. Hruby, V J

    1. Modulation of morphine antinociception by swim-stress in the mouse: involvement of supraspinal opioid delta-2 receptors.
      T W Vanderah, K D Wild, A E Takemori, M Sultana, P S Portoghese, W D Bowen, V J Hruby, H I Mosberg and F Porreca
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 449-455;

  15. Hyde, J F

    1. Prolactin increases Na+/taurocholate cotransport in isolated hepatocytes from postpartum rats and ovariectomized rats.
      T Ganguly, J F Hyde and M Vore
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 82-87;

I

  1. Iino, T

    1. (+-)-Methyl-2,3,3a,4-tetrahydro-1H-indolo [3,2,1-de] [1,5] naphthyridine-6-carboxylate monohydrochloride facilitates phosphatidylinositol hydrolysis: possible involvement of muscarinic and nonmuscarinic mechanisms.
      M Katsura, T Iino and K Kuriyama
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 192-196;

  2. Iwamoto, E T

    1. Multiple spinal mediators in parenteral nicotine-induced antinociception.
      D T Rogers and E T Iwamoto
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 341-349;

  3. Izenwasser, S

    1. Differential regulation of adenylyl cyclase activity by mu and delta opioids in rat caudate putamen and nucleus accumbens.
      S Izenwasser, B Búzás and B M Cox
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 145-152;
    2. Naltrexone-induced upregulation of mu opioid receptors on 7315c cell and brain membranes: enhancement of opioid efficacy in inhibiting adenylyl cyclase.
      T E Côté, S Izenwasser and H B Weems
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 238-244;

J

  1. Jacoby, H I

    1. Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol.
      R B Raffa, E Friderichs, W Reimann, R P Shank, E E Codd, J L Vaught, H I Jacoby and N Selve
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 331-340;

  2. Jeanneton, O

    1. Platelet-activating factor (PAF) induces a contraction of isolated smooth muscle cells from guinea pig ileum: intracellular pathway involved.
      O Jeanneton, M Delvaux, A Botella, J Frexinos and L Bueno
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 31-37;

  3. Jia, L

    1. Inhibition by sulfhydryl compounds of vascular relaxation induced by nitric oxide and endothelium-derived relaxing factor.
      L Jia and R F Furchgott
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 371-378;

  4. Johanson, C E

    1. The discriminative stimulus effects of cocaine in pigeons.
      C E Johanson and J E Barrett
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 1-8;

K

  1. Kaiser, J

    1. The effects of the potent glucocorticoid budesonide on adhesion of eosinophils to human vascular endothelial cells and on endothelial expression of adhesion molecules.
      J Kaiser, C A Bickel, B S Bochner and R P Schleimer
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 245-249;

  2. Kalivas, P W

    1. Involvement of N-methyl-D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine.
      P W Kalivas and J E Alesdatter
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 486-495;

  3. Kanes, S J

    1. On the relationship between D2 receptor density and neuroleptic-induced catalepsy among eight inbred strains of mice.
      S J Kanes, B A Hitzemann and R J Hitzemann
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 538-547;

  4. Kapusta, D R

    1. Central kappa opioid receptor-evoked changes in renal function in conscious rats: participation of renal nerves.
      D R Kapusta and J C Obih
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 197-204;

  5. Katsura, M

    1. (+-)-Methyl-2,3,3a,4-tetrahydro-1H-indolo [3,2,1-de] [1,5] naphthyridine-6-carboxylate monohydrochloride facilitates phosphatidylinositol hydrolysis: possible involvement of muscarinic and nonmuscarinic mechanisms.
      M Katsura, T Iino and K Kuriyama
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 192-196;

  6. Katz, J L

    1. Role of dopamine D1 receptors in the lethal effects of cocaine and a quaternary methiodide analog.
      J M Witkin, A H Newman, G Nowak and J L Katz
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 266-274;

  7. Kays, J S

    1. Pharmacological examination of receptors mediating contractile responses to tachykinins in airways isolated from human, guinea pig and hamster.
      J L Ellis, B J Undem, J S Kays, S V Ghanekar, H G Barthlow and C K Buckner
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 95-101;

  8. Kebabian, J W

    1. Differential effect of selective D-1 and D-2 dopamine receptor agonists on levodopa-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- exposed monkeys.
      P Blanchet, P J Bédard, D R Britton and J W Kebabian
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 275-279;

  9. Kedzierski, W

    1. Localization of a defect in hypothalamic dopaminergic neurons of the aged brain that results in impaired PKA-dependent activation of tyrosine hydroxylase.
      N Aguila-Mansilla, W Kedzierski and J C Porter
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 171-175;

  10. Kerkvliet, N I

    1. Polychlorinated biphenyl-induced immune suppression: castration, but not adrenalectomy or RU 38486 treatment, partially restores the suppressed cytotoxic T lymphocyte response to alloantigen.
      G K De Krey, L Baecher-Steppan, J A Deyo, B Smith and N I Kerkvliet
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 308-315;

  11. Khan, S A

    1. Synergistic effects of glyburide and U-37883A, two structurally different vascular ATP-sensitive potassium channel antagonists.
      C E Ohrnberger, S A Khan and K D Meisheri
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 25-30;

  12. Kim, M K

    1. Possible novel action of ouabain: allosteric modulation of vascular serotonergic (5-HT2) and angiotensinergic (AT1) receptors.
      R E Purdy, B A Prins, M A Weber, A Bakhtiarian, J R Smith, M K Kim, T H Nguyen and E W Weiler
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 228-237;

  13. Kinter, L B

    1. Urea transport in toad skin (Bufo marinus)
      G Dytko, P L Smith and L B Kinter
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 364-370;

  14. Koek, W

    1. Inhibition of methylphenidate-induced behaviors in rats: differences among neuroleptics.
      W Koek and F C Colpaert
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 181-191;

  15. Kohlsdorfer, C

    1. BAY X1005, a new inhibitor of leukotriene synthesis: in vivo inflammation pharmacology and pharmacokinetics.
      R Müller-Peddinghaus, C Kohlsdorfer, P Theisen-Popp, R Fruchtmann, E Perzborn, B Beckermann, K Bühner, H J Ahr and K H Mohrs
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 51-57;

  16. Koob, G F

    1. Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: genetic and motivational determinants.
      F Weiss, M T Lorang, F E Bloom and G F Koob
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 250-258;

  17. Korneyev, A

    1. Stimulation of brain steroidogenesis by 2-aryl-indole-3-acetamide derivatives acting at the mitochondrial diazepam-binding inhibitor receptor complex.
      E Romeo, S Cavallaro, A Korneyev, A P Kozikowski, D Ma, A Polo, E Costa and A Guidotti
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 462-471;

  18. Kozikowski, A P

    1. Stimulation of brain steroidogenesis by 2-aryl-indole-3-acetamide derivatives acting at the mitochondrial diazepam-binding inhibitor receptor complex.
      E Romeo, S Cavallaro, A Korneyev, A P Kozikowski, D Ma, A Polo, E Costa and A Guidotti
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 462-471;

  19. Krämer, H J

    1. Differential vasoconstrictor potencies of free fatty acids in the lung vasculature: 2-versus 3-series prostanoid generation.
      F Grimminger, K Mayer, H J Krämer, J Stevens, D Walmrath and W Seeger
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 259-265;

  20. Krecic, M E

    1. Effects of aminohydroxybutane bisphosphonate on bone growth when administered after hind-limb bone loss in tail-suspended rats.
      G Apseloff, B Girten, S E Weisbrode, M Walker, L S Stern, M E Krecic and N Gerber
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 515-521;

  21. Kribben, A

    1. Calcium modulation and cell injury in isolated rat proximal tubules.
      J F Wetzels, L Yu, X Wang, A Kribben, T J Burke and R W Schrier
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 176-180;

  22. Kuriyama, K

    1. (+-)-Methyl-2,3,3a,4-tetrahydro-1H-indolo [3,2,1-de] [1,5] naphthyridine-6-carboxylate monohydrochloride facilitates phosphatidylinositol hydrolysis: possible involvement of muscarinic and nonmuscarinic mechanisms.
      M Katsura, T Iino and K Kuriyama
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 192-196;

  23. Kuswik-Rabiega, G

    1. Duration and dose-related effects of an orally administered, partially lipophilic polyaminocarboxylic acid on the decorporation of plutonium and americium.
      S C Miller, F W Bruenger, G Kuswik-Rabiega, G Liu and R D Lloyd
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 548-554;

  24. Kwan, E

    1. Transplacental and nonplacental clearances, metabolism and pharmacodynamics of labetalol in the fetal lamb after direct intravenous administration.
      K Yeleswaram, D W Rurak, E Kwan, C Hall, A Doroudian, M R Wright, F S Abbott and J E Axelson
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 425-431;

L

  1. Larach, D R

    1. Potassium channel blockade and halothane vasodilation in conducting and resistance coronary arteries.
      D R Larach and H G Schuler
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 72-81;

  2. Leander, J D

    1. Preclinical studies on LY228729: a potent and selective serotonin1A agonist.
      M M Foreman, R W Fuller, J D Leander, M J Benvenga, D T Wong, D L Nelson, D O Calligaro, S P Swanson, J B Lucot and M E Flaugh
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 58-71;

  3. Lemaire, S

    1. Characterization of [125I][Ser1]histogranin binding sites in rat brain.
      C Rogers and S Lemaire
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 350-356;

  4. Levier, D G

    1. Hepatic and splenic phagocytosis in female B6C3F1 mice implanted with morphine sulfate pellets.
      D G Levier, R D Brown, J A McCay, B A Fuchs, L S Harris and A E Munson
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 357-363;

  5. Liang, J S

    1. Use of m1-toxin as a selective antagonist of m1 muscarinic receptors.
      S I Max, J S Liang, H H Valentine and L T Potter
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 480-485;

  6. Linville, D G

    1. Nicotinic agonists modulate basal forebrain control of cortical cerebral blood flow in anesthetized rats.
      D G Linville, S Williams, J L Raszkiewicz and S P Arneric
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 440-448;

  7. Liu, G

    1. Duration and dose-related effects of an orally administered, partially lipophilic polyaminocarboxylic acid on the decorporation of plutonium and americium.
      S C Miller, F W Bruenger, G Kuswik-Rabiega, G Liu and R D Lloyd
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 548-554;

  8. Lloyd, R D

    1. Duration and dose-related effects of an orally administered, partially lipophilic polyaminocarboxylic acid on the decorporation of plutonium and americium.
      S C Miller, F W Bruenger, G Kuswik-Rabiega, G Liu and R D Lloyd
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 548-554;

  9. Longo, K P

    1. Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor.
      S McLean, A Ganong, P A Seymour, R M Snider, M C Desai, T Rosen, D K Bryce, K P Longo, L S Reynolds and G Robinson
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 472-479;

  10. Lorang, M T

    1. Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: genetic and motivational determinants.
      F Weiss, M T Lorang, F E Bloom and G F Koob
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 250-258;

  11. Lucot, J B

    1. Preclinical studies on LY228729: a potent and selective serotonin1A agonist.
      M M Foreman, R W Fuller, J D Leander, M J Benvenga, D T Wong, D L Nelson, D O Calligaro, S P Swanson, J B Lucot and M E Flaugh
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 58-71;

  12. Luthin, G R

    1. Effect of chronic neuroleptic treatment on central and peripheral muscarinic receptors.
      T A Cawley, T J Shickley, M R Ruggieri and G R Luthin
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 134-139;

M

  1. Ma, D

    1. Stimulation of brain steroidogenesis by 2-aryl-indole-3-acetamide derivatives acting at the mitochondrial diazepam-binding inhibitor receptor complex.
      E Romeo, S Cavallaro, A Korneyev, A P Kozikowski, D Ma, A Polo, E Costa and A Guidotti
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 462-471;

  2. Markus, R P

    1. Age-related changes in norepinephrine release and its modulation by presynaptic alpha-2 adrenoceptors in the rat vas deferens.
      M C de Avellar and R P Markus
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 38-44;

  3. Martin, T J

    1. Effects of intracerebroventricular administration of beta-funaltrexamine on [3H]DAMGO binding to rat brain sections.
      T J Martin, S I Dworkin and J E Smith
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 506-514;

  4. Max, S I

    1. Use of m1-toxin as a selective antagonist of m1 muscarinic receptors.
      S I Max, J S Liang, H H Valentine and L T Potter
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 480-485;

  5. Mayer, A M

    1. Modulation of superoxide anion generation by manoalide, arachidonic acid and staurosporine in liver infiltrated neutrophils in a rat model of endotoxemia.
      A M Mayer and J A Spitzer
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 400-409;

  6. Mayer, K

    1. Differential vasoconstrictor potencies of free fatty acids in the lung vasculature: 2-versus 3-series prostanoid generation.
      F Grimminger, K Mayer, H J Krämer, J Stevens, D Walmrath and W Seeger
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 259-265;

  7. McCay, J A

    1. Hepatic and splenic phagocytosis in female B6C3F1 mice implanted with morphine sulfate pellets.
      D G Levier, R D Brown, J A McCay, B A Fuchs, L S Harris and A E Munson
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 357-363;

  8. McCown, T J

    1. Molecular basis for regionally specific action of ethanol on gamma-aminobutyric acidA receptors: generalization to other ligand-gated ion channels.
      H E Criswell, P E Simson, G E Duncan, T J McCown, J S Herbert, A L Morrow and G R Breese
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 522-537;

  9. McCullough, J R

    1. Cardioprotective effects of a novel calcium antagonist related to the structure of cromakalim.
      G J Grover, P G Sleph, S Dzwonczyk and J R McCullough
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 102-107;

  10. McLean, M J

    1. Phenytoin blocks N-methyl-D-aspartate responses of mouse central neurons.
      A W Wamil and M J McLean
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 218-227;

  11. McLean, S

    1. Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor.
      S McLean, A Ganong, P A Seymour, R M Snider, M C Desai, T Rosen, D K Bryce, K P Longo, L S Reynolds and G Robinson
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 472-479;

  12. Meisheri, K D

    1. Synergistic effects of glyburide and U-37883A, two structurally different vascular ATP-sensitive potassium channel antagonists.
      C E Ohrnberger, S A Khan and K D Meisheri
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 25-30;

  13. Miller, S C

    1. Duration and dose-related effects of an orally administered, partially lipophilic polyaminocarboxylic acid on the decorporation of plutonium and americium.
      S C Miller, F W Bruenger, G Kuswik-Rabiega, G Liu and R D Lloyd
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 548-554;

  14. Mohrs, K H

    1. BAY X1005, a new inhibitor of leukotriene synthesis: in vivo inflammation pharmacology and pharmacokinetics.
      R Müller-Peddinghaus, C Kohlsdorfer, P Theisen-Popp, R Fruchtmann, E Perzborn, B Beckermann, K Bühner, H J Ahr and K H Mohrs
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 51-57;

  15. Morrow, A L

    1. Molecular basis for regionally specific action of ethanol on gamma-aminobutyric acidA receptors: generalization to other ligand-gated ion channels.
      H E Criswell, P E Simson, G E Duncan, T J McCown, J S Herbert, A L Morrow and G R Breese
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 522-537;

  16. Mosberg, H I

    1. Modulation of morphine antinociception by swim-stress in the mouse: involvement of supraspinal opioid delta-2 receptors.
      T W Vanderah, K D Wild, A E Takemori, M Sultana, P S Portoghese, W D Bowen, V J Hruby, H I Mosberg and F Porreca
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 449-455;

  17. Mueller, J L

    1. Dose-dependent antagonism and potentiation of nitrous oxide antinociception by naloxone in mice.
      R M Quock, B A Curtis, B J Reynolds and J L Mueller
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 117-122;

  18. Mulder, A H

    1. Mu- and delta-opioid receptors inhibitorily linked to dopamine-sensitive adenylate cyclase in rat striatum display a selectivity profile toward endogenous opioid peptides different from that of presynaptic mu, delta and kappa receptors.
      A N Schoffelmeer, T J De Vries, F Hogenboom and A H Mulder
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 205-210;

  19. Müller, M

    1. Anticonvulsant and related effects of U-54494A in various seizure tests.
      W Fischer, R Bodewei, P F VonVoigtlander and M Müller
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 163-170;

  20. Müller-Peddinghaus, R

    1. BAY X1005, a new inhibitor of leukotriene synthesis: in vivo inflammation pharmacology and pharmacokinetics.
      R Müller-Peddinghaus, C Kohlsdorfer, P Theisen-Popp, R Fruchtmann, E Perzborn, B Beckermann, K Bühner, H J Ahr and K H Mohrs
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 51-57;

  21. Munson, A E

    1. Hepatic and splenic phagocytosis in female B6C3F1 mice implanted with morphine sulfate pellets.
      D G Levier, R D Brown, J A McCay, B A Fuchs, L S Harris and A E Munson
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 357-363;

N

  1. Natarajan, V

    1. Combined inhibition of neutral endopeptidase and angiotensin converting enzyme in cardiomyopathic hamsters with compensated heart failure.
      N C Trippodo, M Fox, V Natarajan, B C Panchal, C R Dorso and M M Asaad
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 108-116;

  2. Näveri, L

    1. Extracellular catecholamine levels in rat hippocampus after a selective alpha-2 adrenoceptor antagonist or a selective dopamine uptake inhibitor: evidence for dopamine release from local dopaminergic nerve terminals.
      K Xu, L Näveri, K U Frerichs, J M Hallenbeck, G Feuerstein, J N Davis and A L Sirén
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 211-217;

  3. Nelson, D L

    1. Preclinical studies on LY228729: a potent and selective serotonin1A agonist.
      M M Foreman, R W Fuller, J D Leander, M J Benvenga, D T Wong, D L Nelson, D O Calligaro, S P Swanson, J B Lucot and M E Flaugh
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 58-71;

  4. Newman, A H

    1. Role of dopamine D1 receptors in the lethal effects of cocaine and a quaternary methiodide analog.
      J M Witkin, A H Newman, G Nowak and J L Katz
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 266-274;

  5. Nguyen, T H

    1. Possible novel action of ouabain: allosteric modulation of vascular serotonergic (5-HT2) and angiotensinergic (AT1) receptors.
      R E Purdy, B A Prins, M A Weber, A Bakhtiarian, J R Smith, M K Kim, T H Nguyen and E W Weiler
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 228-237;

  6. Nowak, G

    1. Role of dopamine D1 receptors in the lethal effects of cocaine and a quaternary methiodide analog.
      J M Witkin, A H Newman, G Nowak and J L Katz
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 266-274;

O

  1. Obih, J C

    1. Central kappa opioid receptor-evoked changes in renal function in conscious rats: participation of renal nerves.
      D R Kapusta and J C Obih
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 197-204;

  2. Ohrnberger, C E

    1. Synergistic effects of glyburide and U-37883A, two structurally different vascular ATP-sensitive potassium channel antagonists.
      C E Ohrnberger, S A Khan and K D Meisheri
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 25-30;

P

  1. Panchal, B C

    1. Combined inhibition of neutral endopeptidase and angiotensin converting enzyme in cardiomyopathic hamsters with compensated heart failure.
      N C Trippodo, M Fox, V Natarajan, B C Panchal, C R Dorso and M M Asaad
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 108-116;

  2. Payza, K

    1. Neuropeptide FF receptors: structure-activity relationship and effect of morphine.
      K Payza, C A Akar and H Y Yang
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 88-94;

  3. Peppard, J V

    1. Development of tolerance to the antihypertensive effects of highly selective adenosine A2a agonists upon chronic administration.
      R L Webb, M A Sills, J P Chovan, J V Peppard and J E Francis
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 287-295;

  4. Perry, K W

    1. Possible involvement of dopamine in the long-term serotonin depletion by p-chloroamphetamine and beta,beta-difluoro-p-chloroamphetamine in rats.
      M G Henderson, K W Perry and R W Fuller
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 417-424;

  5. Perzborn, E

    1. BAY X1005, a new inhibitor of leukotriene synthesis: in vivo inflammation pharmacology and pharmacokinetics.
      R Müller-Peddinghaus, C Kohlsdorfer, P Theisen-Popp, R Fruchtmann, E Perzborn, B Beckermann, K Bühner, H J Ahr and K H Mohrs
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 51-57;

  6. Polo, A

    1. Stimulation of brain steroidogenesis by 2-aryl-indole-3-acetamide derivatives acting at the mitochondrial diazepam-binding inhibitor receptor complex.
      E Romeo, S Cavallaro, A Korneyev, A P Kozikowski, D Ma, A Polo, E Costa and A Guidotti
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 462-471;

  7. Porreca, F

    1. Modulation of morphine antinociception by swim-stress in the mouse: involvement of supraspinal opioid delta-2 receptors.
      T W Vanderah, K D Wild, A E Takemori, M Sultana, P S Portoghese, W D Bowen, V J Hruby, H I Mosberg and F Porreca
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 449-455;

  8. Porter, J C

    1. Localization of a defect in hypothalamic dopaminergic neurons of the aged brain that results in impaired PKA-dependent activation of tyrosine hydroxylase.
      N Aguila-Mansilla, W Kedzierski and J C Porter
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 171-175;

  9. Portoghese, P S

    1. Modulation of morphine antinociception by swim-stress in the mouse: involvement of supraspinal opioid delta-2 receptors.
      T W Vanderah, K D Wild, A E Takemori, M Sultana, P S Portoghese, W D Bowen, V J Hruby, H I Mosberg and F Porreca
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 449-455;

  10. Potter, L T

    1. Use of m1-toxin as a selective antagonist of m1 muscarinic receptors.
      S I Max, J S Liang, H H Valentine and L T Potter
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 480-485;

  11. Preston, K L

    1. Effects of cocaine alone and in combination with mazindol in human cocaine abusers.
      K L Preston, J T Sullivan, P Berger and G E Bigelow
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 296-307;

  12. Prins, B A

    1. Possible novel action of ouabain: allosteric modulation of vascular serotonergic (5-HT2) and angiotensinergic (AT1) receptors.
      R E Purdy, B A Prins, M A Weber, A Bakhtiarian, J R Smith, M K Kim, T H Nguyen and E W Weiler
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 228-237;

  13. Purdy, R E

    1. Possible novel action of ouabain: allosteric modulation of vascular serotonergic (5-HT2) and angiotensinergic (AT1) receptors.
      R E Purdy, B A Prins, M A Weber, A Bakhtiarian, J R Smith, M K Kim, T H Nguyen and E W Weiler
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 228-237;

Q

  1. Quock, R M

    1. Dose-dependent antagonism and potentiation of nitrous oxide antinociception by naloxone in mice.
      R M Quock, B A Curtis, B J Reynolds and J L Mueller
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 117-122;

R

  1. Raffa, R B

    1. Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol.
      R B Raffa, E Friderichs, W Reimann, R P Shank, E E Codd, J L Vaught, H I Jacoby and N Selve
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 331-340;

  2. Raszkiewicz, J L

    1. Nicotinic agonists modulate basal forebrain control of cortical cerebral blood flow in anesthetized rats.
      D G Linville, S Williams, J L Raszkiewicz and S P Arneric
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 440-448;

  3. Ravindranath, V

    1. Cerebral flavin-containing monooxygenase-mediated metabolism of antidepressants in brain: immunochemical properties and immunocytochemical localization.
      S Bhamre, S V Bhagwat, S K Shankar, D E Williams and V Ravindranath
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 555-559;

  4. Reimann, W

    1. Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol.
      R B Raffa, E Friderichs, W Reimann, R P Shank, E E Codd, J L Vaught, H I Jacoby and N Selve
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 331-340;

  5. Reith, M E

    1. [3H]dopamine and [3H]serotonin release in vitro induced by electrical stimulation in A9 and A10 dopamine regions of rat brain: characterization and responsiveness to cocaine.
      N H Chen and M E Reith
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 379-389;

  6. Reynolds, B J

    1. Dose-dependent antagonism and potentiation of nitrous oxide antinociception by naloxone in mice.
      R M Quock, B A Curtis, B J Reynolds and J L Mueller
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 117-122;

  7. Reynolds, L S

    1. Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor.
      S McLean, A Ganong, P A Seymour, R M Snider, M C Desai, T Rosen, D K Bryce, K P Longo, L S Reynolds and G Robinson
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 472-479;

  8. Richelson, E

    1. Role of signal transduction systems in neurotensin receptor down-regulation induced by agonist in murine neuroblastoma clone N1E-115 cells.
      M Yamada, M Yamada and E Richelson
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 128-133;

  9. Robinson, G

    1. Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor.
      S McLean, A Ganong, P A Seymour, R M Snider, M C Desai, T Rosen, D K Bryce, K P Longo, L S Reynolds and G Robinson
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 472-479;

  10. Rogers, C

    1. Characterization of [125I][Ser1]histogranin binding sites in rat brain.
      C Rogers and S Lemaire
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 350-356;

  11. Rogers, D T

    1. Multiple spinal mediators in parenteral nicotine-induced antinociception.
      D T Rogers and E T Iwamoto
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 341-349;

  12. Romeo, E

    1. Stimulation of brain steroidogenesis by 2-aryl-indole-3-acetamide derivatives acting at the mitochondrial diazepam-binding inhibitor receptor complex.
      E Romeo, S Cavallaro, A Korneyev, A P Kozikowski, D Ma, A Polo, E Costa and A Guidotti
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 462-471;

  13. Rosen, T

    1. Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor.
      S McLean, A Ganong, P A Seymour, R M Snider, M C Desai, T Rosen, D K Bryce, K P Longo, L S Reynolds and G Robinson
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 472-479;

  14. Ruggieri, M R

    1. Effect of chronic neuroleptic treatment on central and peripheral muscarinic receptors.
      T A Cawley, T J Shickley, M R Ruggieri and G R Luthin
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 134-139;

  15. Rurak, D W

    1. Transplacental and nonplacental clearances, metabolism and pharmacodynamics of labetalol in the fetal lamb after direct intravenous administration.
      K Yeleswaram, D W Rurak, E Kwan, C Hall, A Doroudian, M R Wright, F S Abbott and J E Axelson
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 425-431;

S

  1. Sargent, C

    1. ATP-sensitive potassium channels and skeletal muscle function in vitro.
      E O Weselcouch, C Sargent, M W Wilde and M A Smith
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 410-416;

  2. Satoh, S

    1. Effects of nifedipine, 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate hydrochloride and atrial natriuretic peptide on endothelin-induced antinatriuresis in dogs.
      H Takagi, A Takahara, Y Tomura, T Yamagata, H Hisa and S Satoh
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 456-461;

  3. Schindler, C W

    1. Cocaine: cardiovascular effects in relation to inhibition of peripheral neuronal monoamine uptake and central stimulation of the sympathoadrenal system.
      S R Tella, C W Schindler and S R Goldberg
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 153-162;

  4. Schleimer, R P

    1. The effects of the potent glucocorticoid budesonide on adhesion of eosinophils to human vascular endothelial cells and on endothelial expression of adhesion molecules.
      J Kaiser, C A Bickel, B S Bochner and R P Schleimer
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 245-249;

  5. Schoffelmeer, A N

    1. Mu- and delta-opioid receptors inhibitorily linked to dopamine-sensitive adenylate cyclase in rat striatum display a selectivity profile toward endogenous opioid peptides different from that of presynaptic mu, delta and kappa receptors.
      A N Schoffelmeer, T J De Vries, F Hogenboom and A H Mulder
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 205-210;

  6. Schrier, R W

    1. Calcium modulation and cell injury in isolated rat proximal tubules.
      J F Wetzels, L Yu, X Wang, A Kribben, T J Burke and R W Schrier
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 176-180;

  7. Schuler, H G

    1. Potassium channel blockade and halothane vasodilation in conducting and resistance coronary arteries.
      D R Larach and H G Schuler
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 72-81;

  8. Seeger, W

    1. Differential vasoconstrictor potencies of free fatty acids in the lung vasculature: 2-versus 3-series prostanoid generation.
      F Grimminger, K Mayer, H J Krämer, J Stevens, D Walmrath and W Seeger
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 259-265;

  9. Seiger, A

    1. Systemic excitatory amino acid receptor antagonists of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor and of the N-methyl-D-aspartate (NMDA) receptor relieve mechanical hypersensitivity after transient spinal cord ischemia in rats.
      X J Xu, J X Hao, A Seiger and Z Wiesenfeld-Hallin
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 140-144;

  10. Selve, N

    1. Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol.
      R B Raffa, E Friderichs, W Reimann, R P Shank, E E Codd, J L Vaught, H I Jacoby and N Selve
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 331-340;

  11. Seymour, P A

    1. Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor.
      S McLean, A Ganong, P A Seymour, R M Snider, M C Desai, T Rosen, D K Bryce, K P Longo, L S Reynolds and G Robinson
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 472-479;

  12. Shank, R P

    1. Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol.
      R B Raffa, E Friderichs, W Reimann, R P Shank, E E Codd, J L Vaught, H I Jacoby and N Selve
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 331-340;

  13. Shankar, S K

    1. Cerebral flavin-containing monooxygenase-mediated metabolism of antidepressants in brain: immunochemical properties and immunocytochemical localization.
      S Bhamre, S V Bhagwat, S K Shankar, D E Williams and V Ravindranath
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 555-559;

  14. Shannon, H E

    1. Comparative behavioral and neurochemical activities of cholinergic antagonists in rats.
      F P Bymaster, I Heath, J C Hendrix and H E Shannon
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 16-24;

  15. Shickley, T J

    1. Effect of chronic neuroleptic treatment on central and peripheral muscarinic receptors.
      T A Cawley, T J Shickley, M R Ruggieri and G R Luthin
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 134-139;

  16. Silbernagl, S

    1. Mechanism of ochratoxin A-induced reduction of glomerular filtration rate in rats.
      M Gekle and S Silbernagl
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 316-321;

  17. Sills, M A

    1. Development of tolerance to the antihypertensive effects of highly selective adenosine A2a agonists upon chronic administration.
      R L Webb, M A Sills, J P Chovan, J V Peppard and J E Francis
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 287-295;

  18. Simson, P E

    1. Molecular basis for regionally specific action of ethanol on gamma-aminobutyric acidA receptors: generalization to other ligand-gated ion channels.
      H E Criswell, P E Simson, G E Duncan, T J McCown, J S Herbert, A L Morrow and G R Breese
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 522-537;

  19. Sirén, A L

    1. Extracellular catecholamine levels in rat hippocampus after a selective alpha-2 adrenoceptor antagonist or a selective dopamine uptake inhibitor: evidence for dopamine release from local dopaminergic nerve terminals.
      K Xu, L Näveri, K U Frerichs, J M Hallenbeck, G Feuerstein, J N Davis and A L Sirén
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 211-217;

  20. Sleph, P G

    1. Cardioprotective effects of a novel calcium antagonist related to the structure of cromakalim.
      G J Grover, P G Sleph, S Dzwonczyk and J R McCullough
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 102-107;

  21. Smith, B

    1. Polychlorinated biphenyl-induced immune suppression: castration, but not adrenalectomy or RU 38486 treatment, partially restores the suppressed cytotoxic T lymphocyte response to alloantigen.
      G K De Krey, L Baecher-Steppan, J A Deyo, B Smith and N I Kerkvliet
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 308-315;

  22. Smith, J E

    1. Effects of intracerebroventricular administration of beta-funaltrexamine on [3H]DAMGO binding to rat brain sections.
      T J Martin, S I Dworkin and J E Smith
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 506-514;

  23. Smith, J R

    1. Possible novel action of ouabain: allosteric modulation of vascular serotonergic (5-HT2) and angiotensinergic (AT1) receptors.
      R E Purdy, B A Prins, M A Weber, A Bakhtiarian, J R Smith, M K Kim, T H Nguyen and E W Weiler
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 228-237;

  24. Smith, M A

    1. ATP-sensitive potassium channels and skeletal muscle function in vitro.
      E O Weselcouch, C Sargent, M W Wilde and M A Smith
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 410-416;

  25. Smith, P L

    1. Urea transport in toad skin (Bufo marinus)
      G Dytko, P L Smith and L B Kinter
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 364-370;

  26. Snider, R M

    1. Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor.
      S McLean, A Ganong, P A Seymour, R M Snider, M C Desai, T Rosen, D K Bryce, K P Longo, L S Reynolds and G Robinson
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 472-479;

  27. Spitzer, J A

    1. Modulation of superoxide anion generation by manoalide, arachidonic acid and staurosporine in liver infiltrated neutrophils in a rat model of endotoxemia.
      A M Mayer and J A Spitzer
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 400-409;

  28. Stern, L S

    1. Effects of aminohydroxybutane bisphosphonate on bone growth when administered after hind-limb bone loss in tail-suspended rats.
      G Apseloff, B Girten, S E Weisbrode, M Walker, L S Stern, M E Krecic and N Gerber
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 515-521;

  29. Stevens, J

    1. Differential vasoconstrictor potencies of free fatty acids in the lung vasculature: 2-versus 3-series prostanoid generation.
      F Grimminger, K Mayer, H J Krämer, J Stevens, D Walmrath and W Seeger
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 259-265;

  30. Sullivan, J T

    1. Effects of cocaine alone and in combination with mazindol in human cocaine abusers.
      K L Preston, J T Sullivan, P Berger and G E Bigelow
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 296-307;

  31. Sultana, M

    1. Modulation of morphine antinociception by swim-stress in the mouse: involvement of supraspinal opioid delta-2 receptors.
      T W Vanderah, K D Wild, A E Takemori, M Sultana, P S Portoghese, W D Bowen, V J Hruby, H I Mosberg and F Porreca
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 449-455;

  32. Swanson, S P

    1. Preclinical studies on LY228729: a potent and selective serotonin1A agonist.
      M M Foreman, R W Fuller, J D Leander, M J Benvenga, D T Wong, D L Nelson, D O Calligaro, S P Swanson, J B Lucot and M E Flaugh
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 58-71;

T

  1. Takagi, H

    1. Effects of nifedipine, 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate hydrochloride and atrial natriuretic peptide on endothelin-induced antinatriuresis in dogs.
      H Takagi, A Takahara, Y Tomura, T Yamagata, H Hisa and S Satoh
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 456-461;

  2. Takahara, A

    1. Effects of nifedipine, 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate hydrochloride and atrial natriuretic peptide on endothelin-induced antinatriuresis in dogs.
      H Takagi, A Takahara, Y Tomura, T Yamagata, H Hisa and S Satoh
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 456-461;

  3. Takemori, A E

    1. Modulation of morphine antinociception by swim-stress in the mouse: involvement of supraspinal opioid delta-2 receptors.
      T W Vanderah, K D Wild, A E Takemori, M Sultana, P S Portoghese, W D Bowen, V J Hruby, H I Mosberg and F Porreca
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 449-455;

  4. Tella, S R

    1. Cocaine: cardiovascular effects in relation to inhibition of peripheral neuronal monoamine uptake and central stimulation of the sympathoadrenal system.
      S R Tella, C W Schindler and S R Goldberg
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 153-162;

  5. Theisen-Popp, P

    1. BAY X1005, a new inhibitor of leukotriene synthesis: in vivo inflammation pharmacology and pharmacokinetics.
      R Müller-Peddinghaus, C Kohlsdorfer, P Theisen-Popp, R Fruchtmann, E Perzborn, B Beckermann, K Bühner, H J Ahr and K H Mohrs
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 51-57;

  6. Toews, M L

    1. Effects of antimycin A on the binding properties of beta and alpha-1 adrenergic receptors measured on intact cells.
      S J Zhu and M L Toews
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 123-127;

  7. Tomura, Y

    1. Effects of nifedipine, 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate hydrochloride and atrial natriuretic peptide on endothelin-induced antinatriuresis in dogs.
      H Takagi, A Takahara, Y Tomura, T Yamagata, H Hisa and S Satoh
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 456-461;

  8. Trippodo, N C

    1. Combined inhibition of neutral endopeptidase and angiotensin converting enzyme in cardiomyopathic hamsters with compensated heart failure.
      N C Trippodo, M Fox, V Natarajan, B C Panchal, C R Dorso and M M Asaad
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 108-116;

U

  1. Undem, B J

    1. Pharmacological examination of receptors mediating contractile responses to tachykinins in airways isolated from human, guinea pig and hamster.
      J L Ellis, B J Undem, J S Kays, S V Ghanekar, H G Barthlow and C K Buckner
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 95-101;

V

  1. Valentine, H H

    1. Use of m1-toxin as a selective antagonist of m1 muscarinic receptors.
      S I Max, J S Liang, H H Valentine and L T Potter
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 480-485;

  2. Vanderah, T W

    1. Modulation of morphine antinociception by swim-stress in the mouse: involvement of supraspinal opioid delta-2 receptors.
      T W Vanderah, K D Wild, A E Takemori, M Sultana, P S Portoghese, W D Bowen, V J Hruby, H I Mosberg and F Porreca
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 449-455;

  3. Vaught, J L

    1. Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol.
      R B Raffa, E Friderichs, W Reimann, R P Shank, E E Codd, J L Vaught, H I Jacoby and N Selve
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 331-340;

  4. VonVoigtlander, P F

    1. Anticonvulsant and related effects of U-54494A in various seizure tests.
      W Fischer, R Bodewei, P F VonVoigtlander and M Müller
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 163-170;

  5. Vore, M

    1. Prolactin increases Na+/taurocholate cotransport in isolated hepatocytes from postpartum rats and ovariectomized rats.
      T Ganguly, J F Hyde and M Vore
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 82-87;

W

  1. Walcott, J

    1. Serotonergic modulation of L-glutamic acid-evoked release of endogenous norepinephrine from rat hypothalamus.
      J Goldfarb, J Walcott and P Blandina
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 45-50;

  2. Walker, E A

    1. Opioid thermal antinociception in rhesus monkeys: receptor mechanisms and temperature dependency.
      E A Walker, E R Butelman, B R DeCosta and J H Woods
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 280-286;
    2. Discriminative-stimulus effects of the low efficacy mu agonist nalbuphine.
      E A Walker and A M Young
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 322-330;

  3. Walker, M

    1. Effects of aminohydroxybutane bisphosphonate on bone growth when administered after hind-limb bone loss in tail-suspended rats.
      G Apseloff, B Girten, S E Weisbrode, M Walker, L S Stern, M E Krecic and N Gerber
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 515-521;

  4. Walmrath, D

    1. Differential vasoconstrictor potencies of free fatty acids in the lung vasculature: 2-versus 3-series prostanoid generation.
      F Grimminger, K Mayer, H J Krämer, J Stevens, D Walmrath and W Seeger
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 259-265;

  5. Wamil, A W

    1. Phenytoin blocks N-methyl-D-aspartate responses of mouse central neurons.
      A W Wamil and M J McLean
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 218-227;

  6. Wang, X

    1. Calcium modulation and cell injury in isolated rat proximal tubules.
      J F Wetzels, L Yu, X Wang, A Kribben, T J Burke and R W Schrier
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 176-180;

  7. Webb, R L

    1. Development of tolerance to the antihypertensive effects of highly selective adenosine A2a agonists upon chronic administration.
      R L Webb, M A Sills, J P Chovan, J V Peppard and J E Francis
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 287-295;

  8. Weber, M A

    1. Possible novel action of ouabain: allosteric modulation of vascular serotonergic (5-HT2) and angiotensinergic (AT1) receptors.
      R E Purdy, B A Prins, M A Weber, A Bakhtiarian, J R Smith, M K Kim, T H Nguyen and E W Weiler
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 228-237;

  9. Weems, H B

    1. Naltrexone-induced upregulation of mu opioid receptors on 7315c cell and brain membranes: enhancement of opioid efficacy in inhibiting adenylyl cyclase.
      T E Côté, S Izenwasser and H B Weems
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 238-244;

  10. Weiler, E W

    1. Possible novel action of ouabain: allosteric modulation of vascular serotonergic (5-HT2) and angiotensinergic (AT1) receptors.
      R E Purdy, B A Prins, M A Weber, A Bakhtiarian, J R Smith, M K Kim, T H Nguyen and E W Weiler
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 228-237;

  11. Weisbrode, S E

    1. Effects of aminohydroxybutane bisphosphonate on bone growth when administered after hind-limb bone loss in tail-suspended rats.
      G Apseloff, B Girten, S E Weisbrode, M Walker, L S Stern, M E Krecic and N Gerber
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 515-521;

  12. Weiss, F

    1. Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: genetic and motivational determinants.
      F Weiss, M T Lorang, F E Bloom and G F Koob
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 250-258;

  13. Welch, S P

    1. Antinociceptive activity of intrathecally administered potassium channel openers and opioid agonists: a common mechanism of action?
      S P Welch and L D Dunlow
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 390-399;

  14. Weselcouch, E O

    1. ATP-sensitive potassium channels and skeletal muscle function in vitro.
      E O Weselcouch, C Sargent, M W Wilde and M A Smith
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 410-416;

  15. Wetzels, J F

    1. Calcium modulation and cell injury in isolated rat proximal tubules.
      J F Wetzels, L Yu, X Wang, A Kribben, T J Burke and R W Schrier
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 176-180;

  16. Wiesenfeld-Hallin, Z

    1. Systemic excitatory amino acid receptor antagonists of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor and of the N-methyl-D-aspartate (NMDA) receptor relieve mechanical hypersensitivity after transient spinal cord ischemia in rats.
      X J Xu, J X Hao, A Seiger and Z Wiesenfeld-Hallin
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 140-144;

  17. Wild, K D

    1. Modulation of morphine antinociception by swim-stress in the mouse: involvement of supraspinal opioid delta-2 receptors.
      T W Vanderah, K D Wild, A E Takemori, M Sultana, P S Portoghese, W D Bowen, V J Hruby, H I Mosberg and F Porreca
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 449-455;

  18. Wilde, M W

    1. ATP-sensitive potassium channels and skeletal muscle function in vitro.
      E O Weselcouch, C Sargent, M W Wilde and M A Smith
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 410-416;

  19. Williams, D E

    1. Cerebral flavin-containing monooxygenase-mediated metabolism of antidepressants in brain: immunochemical properties and immunocytochemical localization.
      S Bhamre, S V Bhagwat, S K Shankar, D E Williams and V Ravindranath
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 555-559;

  20. Williams, S

    1. Nicotinic agonists modulate basal forebrain control of cortical cerebral blood flow in anesthetized rats.
      D G Linville, S Williams, J L Raszkiewicz and S P Arneric
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 440-448;

  21. Witkin, J M

    1. Role of dopamine D1 receptors in the lethal effects of cocaine and a quaternary methiodide analog.
      J M Witkin, A H Newman, G Nowak and J L Katz
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 266-274;

  22. Wong, D T

    1. Preclinical studies on LY228729: a potent and selective serotonin1A agonist.
      M M Foreman, R W Fuller, J D Leander, M J Benvenga, D T Wong, D L Nelson, D O Calligaro, S P Swanson, J B Lucot and M E Flaugh
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 58-71;

  23. Woods, J H

    1. Opioid thermal antinociception in rhesus monkeys: receptor mechanisms and temperature dependency.
      E A Walker, E R Butelman, B R DeCosta and J H Woods
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 280-286;

  24. Wright, M R

    1. Transplacental and nonplacental clearances, metabolism and pharmacodynamics of labetalol in the fetal lamb after direct intravenous administration.
      K Yeleswaram, D W Rurak, E Kwan, C Hall, A Doroudian, M R Wright, F S Abbott and J E Axelson
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 425-431;

  25. Wu, D

    1. Ethanol consumption by the nursing mother induces cytochrome P-4502E1 in neonatal rat liver.
      D Wu and A I Cederbaum
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 560-566;

X

  1. Xu, K

    1. Extracellular catecholamine levels in rat hippocampus after a selective alpha-2 adrenoceptor antagonist or a selective dopamine uptake inhibitor: evidence for dopamine release from local dopaminergic nerve terminals.
      K Xu, L Näveri, K U Frerichs, J M Hallenbeck, G Feuerstein, J N Davis and A L Sirén
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 211-217;

  2. Xu, X J

    1. Systemic excitatory amino acid receptor antagonists of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor and of the N-methyl-D-aspartate (NMDA) receptor relieve mechanical hypersensitivity after transient spinal cord ischemia in rats.
      X J Xu, J X Hao, A Seiger and Z Wiesenfeld-Hallin
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 140-144;

Y

  1. Yamada, M

    1. Role of signal transduction systems in neurotensin receptor down-regulation induced by agonist in murine neuroblastoma clone N1E-115 cells.
      M Yamada, M Yamada and E Richelson
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 128-133;
    2. Role of signal transduction systems in neurotensin receptor down-regulation induced by agonist in murine neuroblastoma clone N1E-115 cells.
      M Yamada, M Yamada and E Richelson
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 128-133;

  2. Yamagata, T

    1. Effects of nifedipine, 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate hydrochloride and atrial natriuretic peptide on endothelin-induced antinatriuresis in dogs.
      H Takagi, A Takahara, Y Tomura, T Yamagata, H Hisa and S Satoh
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 456-461;

  3. Yang, H Y

    1. Neuropeptide FF receptors: structure-activity relationship and effect of morphine.
      K Payza, C A Akar and H Y Yang
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 88-94;

  4. Yeleswaram, K

    1. Transplacental and nonplacental clearances, metabolism and pharmacodynamics of labetalol in the fetal lamb after direct intravenous administration.
      K Yeleswaram, D W Rurak, E Kwan, C Hall, A Doroudian, M R Wright, F S Abbott and J E Axelson
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 425-431;

  5. Young, A M

    1. Discriminative-stimulus effects of the low efficacy mu agonist nalbuphine.
      E A Walker and A M Young
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 322-330;

  6. Yu, L

    1. Calcium modulation and cell injury in isolated rat proximal tubules.
      J F Wetzels, L Yu, X Wang, A Kribben, T J Burke and R W Schrier
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 176-180;

Z

  1. Zhu, S J

    1. Effects of antimycin A on the binding properties of beta and alpha-1 adrenergic receptors measured on intact cells.
      S J Zhu and M L Toews
      Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 123-127;
Back to top

In this issue